The “Powering Milwaukee Forward” initiative is set to enhance access to essential services and maternal healthcare in vulnerable communities across Milwaukee. Launched by GE HealthCare (Nasdaq: GEHC), the GE HealthCare…
The “High Potency APIs (HPAPIs) – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offerings. The global HPAPIs market was valued at $26.3 billion in 2023 and is projected…
bioAffinity Technologies Announces $2.66 Million Offering with Concurrent Private Placement bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology firm dedicated to noninvasive cancer detection, has entered into a securities purchase…
New Report: COPD Drug Market Analysis and Forecast (2024-2033) ResearchAndMarkets.com has released the report “COPD: Seven-Market Drug Forecast and Market Analysis,” detailing the COPD drug market across seven major regions:…
Biological Lattice Industries Secures $1.8 Million Pre-Seed Funding to Democratize Biofabrication Biological Lattice Industries Corp. (BLI), an innovator in biofabrication and life sciences research and development, has successfully closed a…
Trinity Life Sciences Launches New Omnichannel Reporting Suite for Enhanced Marketing Insights Trinity Life Sciences, a leader in strategy, insights, and analytics for the life sciences sector, has unveiled an…
Ferring Pharmaceuticals Showcases Commitment to Advancing Fertility Care at 2024 ASRM Congress Ferring Pharmaceuticals will present new data from four abstracts at the 2024 American Society for Reproductive Medicine (ASRM)…
Successful Cyclotron Irradiation of Ra-226 Paves the Way for Actineer’s Large-Scale Ac-225 Production for Cancer Treatments Actineer, the joint venture between ITM and Canadian Nuclear Laboratories (CNL) Ltd., has achieved…
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) has announced that five of its abstracts have been accepted for e-Poster presentations at the 2024 Annual Scientific Meeting of the American College of Allergy,…
Nordic Pharma, a subsidiary of Nordic Group BV, is advancing the U.S. introduction of LACRIFILL® Canalicular Gel, a novel therapy for dry eye, during the 2024 American Academy of Ophthalmology…
Celltrion has announced two-year findings from a post-hoc analysis of the LIBERTY studies (LIBERTY-CD and LIBERTY-UC), presented at United European Gastroenterology (UEG) Week 2024 in Vienna. The analysis shows that…
Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, has shared positive results from its Phase 2b/3 clinical trial (MK-1654-004) evaluating clesrovimab, an investigational monoclonal antibody designed to…